We are excited to announce that SpiroChem will attend 4 top global conferences in September covering Medicinal Chemistry, Medical Oncology, Drug Design and Fragment-Based Lead Discovery. Our experts will be present and happy to connect with you to discuss the latest hot topics.
EFMC-ISMC 2024, XXVIII EFMC International Symposium on Medicinal Chemistry
With a diverse program presenting current approaches to tackle challenging targets, the EFMC-ISMC event in Rome, Italy, provides a unique opportunity to network and connect. Meet SpiroChem team at booth #35 to learn more about our Integrated MedChem offering and discuss how our experts could accelerate your programs.
Laurence Jung, PhD – BD Manager
Florent Beaufils, PhD – COO
David Pierrot, PhD – Team Leader, Project Leader
Christophe Salomé, PhD – Group leader, Principal Project leader - Medicinal Chemistry Division
ESMO Congress 2024
The ESMO congress is a unique international event gathering clinicians, researchers and healthcare industry representatives to discuss latest trends in oncology. SpiroChem supports diverse programs in cancer research offering integrated MedChem projects including high-potent chemistry. Contact us to schedule meetings in Barcelona with our high-potent lab expert to share more information about our capabilities.
Serghei Chercheja, PhD – Team leader, Project Leader - High-potent Lab
24th European Symposium on Quantitative Structure-Activity Relationship (EuroQSAR)
Explore the forefront of computational drug design at the 24th EuroQSAR Symposium, themed "Synergizing AI and Multiscale Modeling for Drug Discovery," organized by QCMS in Barcelona. Since 1973, this event has been a major milestone, integrating advanced topics like Artificial Intelligence, Generative Models, and Multiscale Modeling.
Contact us to schedule meetings with our computational chemistry expert and learn more on our capabilities.
Colin Bournez, PhD – Research Scientist - Computational Chemistry
Fragment–Based Lead Discovery Conference 2024
We are thrilled to be returning to Boston for FBLD 2024, a great occasion to meet with experts from the fragment-based lead discovery community in chemistry and biochemistry in Boston, USA. Stop by our booth #14 or contact us to get an update on SpiroChem’s new integrated services to support your discovery programs: our CEO and CSO will be on site all week.
Thomas Fessard, PhD - CEO
Gerhard Müller, PhD - CSO
Looking forward to connecting with you at these events to reveal how SpiroChem’s experts can speed up your projects.
